Cell-El's Research

Cell-El’s goal is to research and publish new diagnostic and therapeutic approaches. By sharing our research with the medical and scientific community, Cell-El intends to improve ASD patient care.

Authors: Benjamin Gesundheit, Leah Hochbaum, Alexandra Fetyukhina, Vasily Vorobyev, Nikolay Vorobye 

Description: Autism spectrum disorder (ASD) is associated with significant lifelong challenges for severely affected children and their families. The condition remains poorly understood, and no reliable, effective treatments are available. Presented is a case of a boy with severe ASD, epilepsy, and a pathological electroencephalogram (EEG) who underwent five treatments between the ages of 5.75 years and nine years with mesenchymal stem cells from allogeneic placenta and umbilical cord tissue of unrelated donors. Read more

Publucation: Cureus, May 2025

Authors: Benjamin Gesundheit, Philip David Zisman, Leah Hochbaum, Yehudit Posen, Avraham Steinberg, Gerald Friedman, Hersh D. Ravkin, Eitan Rubin, Ouriel Faktor and Ronald Ellis

Description: Children with autism spectrum disorder (ASD) present with distinctive clinical features. No objective laboratory assay has been developed to establish a diagnosis of ASD. Considering the known immunological associations with ASD, immunological biomarkers might enable ASD diagnosis and intervention at an early age when the immature brain has the highest degree of plasticity. This work aimed to identify diagnostic biomarkers discriminating between children with ASD and typically developing (TD) children. Read more

Publication: Frontiers in Pediatrics, February 2023

Authors: Ashley Ansel, Yehudit Posen, Ronald Ellis, Lisa Deutsch, Philip D. Zisman, and Benjamin Gesundheit

Description: The objective of this paper is to compare the reported accuracy and sensitivity of the various modalities used to diagnose autism spectrum disorders (ASD) in efforts to help focus further biomarker research on the most promising
methods for early diagnosis. Read more

Publication: Rambam Maimonides Medical Journal, October 2019

Editors: Benjamin Gesundheit, Joshua Rosenzweig and Yehuda Shoenfeld

Description: This open-access book compiles evidence of the biological basis of autism spectrum disorders which are setting the stage for understanding the mechanisms underlying the behavioral symptoms of the condition and for development of targeted therapeutics. Read more

Publication: Frontiers in Neuroscience and Frontiers in Pediatrics, February 2017

Authors: Benjamin Gesundheit, Paul Ashwood, Armand Keating, David Naor, Michal Melamed, Joshua P. Rosenzweig

Description: This work presents the rationale behind stem cell-based treatment for autism patients presenting immune and nervous system abnormalities. This approach is regularly applied for the management of a range of immunological and neurological conditions and has proven both effective and safe. Read more

Publication: Medical Hypotheses, December 2014

Authors: Benjamin Gesundheit, Joshua P. Rosenzweig, David Naor, Bernard Lerer, et al.

Description: This paper reviews studies that link between immune dysfunction or abnormalities and autism spectrum disorder. These works bear potential to advance more accurate and objective diagnostics and to identify therapeutic targets for autism management. Read more

Publication: Journal of Autoimmunity, 2013

Presentations

Cell-El presents their research and projects at international conferences

Objective, Blood-Based ASD Diagnostic Test Parents Willingness to Pay

Presented by Charles Piwko and Refoel Guggenheim at the  INSAR Annual Meeting in Prague, April,  2026

Please click on image above to view the full publication

Significant clinical improvement of severe autism spectrum disorder symptoms following mesenchymal stromal cell treatments: case report

Benjamin Gesundheit and Leah Hochbaum, I-MAR at Ben-Gurion University, Beer Sheva, March 2025

Please click on image above to view the full publication

Can Serum Protein Biomarkers Identify Children at High Risk for Autism Spectrum Disorder?

Presented by Fred Samuels, CEO, Cell-El at the Synchrony Symposium, October, 2023

Autism Spectrum Disorders and Stem Cell Therapies: A Promising New Direction

Team: Benjamin Gesundheit, Ronald Ellis, Philip D. Zisman, Nadya Lisovoder, Leah Hochbaum et al.

Description: Cell-El presents projects on the innovative diagnosis and treatment of Autism Spectrum Disorder (ASD). Read more

Presented: January 9, 2019 at the 22nd Conference of the Israeli Society for Child Development and Rehabilitation, Jerusalem.